Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax Vaccines
New anthrax vaccines study findings recently were reported by N. Marano and co-researchers
November 5th, 2008
According to recent research from the United States, "Context In 1999, the US Congress directed the Centers for Disease Control and Prevention to conduct a pivotal safety and efficacy study of anthrax vaccine adsorbed ( AVA). To determine the effects on serological responses and injection site adverse events ( AEs) resulting from changing the route of administration of AVA from subcutaneous ( SQ) to intramuscular ( IM) and omitting the week 2 dose from the licensed schedule." "Setting, and Participants Assessment of the first 1005 enrollees in a multisite, randomized, double- blind, noninferiority, phase 4 human clinical trial ( ongoing from May 2002). Healthy adults...
Source: Vaccine Weekly (2008-11-05)
|
